SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-305767"
 

Search: onr:"swepub:oai:DiVA.org:uu-305767" > A Delphic consensus...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Öberg, KjellUppsala universitet,Endokrin tumörbiologi (author)

A Delphic consensus assessment : imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management

  • Article/chapterEnglish2016

Publisher, publication year, extent ...

  • 2016
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-305767
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-305767URI
  • https://doi.org/10.1530/EC-16-0043DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers. Limitations in currently available imaging modalities reflect difficulties in measuring an intrinsically indolent disease, resolution inadequacies and inter-/intra-facility device variability and that RECIST (Response Evaluation Criteria in Solid Tumors) criteria are not optimal for NEN. Limitations of currently used biomarkers are that they are secretory biomarkers (chromogranin A, serotonin, neuron-specific enolase and pancreastatin); monoanalyte measurements; and lack sensitivity, specificity and predictive capacity. None of them meet the NIH metrics for clinical usage. A multinational, multidisciplinary Delphi consensus meeting of NEN experts (n = 33) assessed current imaging strategies and biomarkers in NEN management. Consensus (>75%) was achieved for 78% of the 142 questions. The panel concluded that morphological imaging has a diagnostic value. However, both imaging and current single-analyte biomarkers exhibit substantial limitations in measuring the disease status and predicting the therapeutic efficacy. RECIST remains suboptimal as a metric. A critical unmet need is the development of a clinico-biological tool to provide enhanced information regarding precise disease status and treatment response. The group considered that circulating RNA was better than current general NEN biomarkers and preliminary clinical data were considered promising. It was resolved that circulating multianalyte mRNA (NETest) had clinical utility in both diagnosis and monitoring disease status and therapeutic efficacy. Overall, it was concluded that a combination of tumor spatial and functional imaging with circulating transcripts (mRNA) would represent the future strategy for real-time monitoring of disease progress and therapeutic efficacy.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Krenning, Eric (author)
  • Sundin, AndersUppsala universitet,Radiologi(Swepub:uu)anderssu (author)
  • Bodei, Lisa (author)
  • Kidd, Mark (author)
  • Tesselaar, Margot (author)
  • Ambrosini, Valentina (author)
  • Baum, Richard P (author)
  • Kulke, Matthew (author)
  • Pavel, Marianne (author)
  • Cwikla, Jaroslaw (author)
  • Drozdov, Ignat (author)
  • Falconi, Massimo (author)
  • Fazio, Nicola (author)
  • Frilling, Andrea (author)
  • Jensen, Robert (author)
  • Koopmans, Klaus (author)
  • Korse, Tiny (author)
  • Kwekkeboom, Dik (author)
  • Maecke, Helmut (author)
  • Paganelli, Giovanni (author)
  • Salazar, Ramon (author)
  • Severi, Stefano (author)
  • Strosberg, Jonathan (author)
  • Prasad, Vikas (author)
  • Scarpa, Aldo (author)
  • Grossman, Ashley (author)
  • Walenkamp, Annemeik (author)
  • Cives, Mauro (author)
  • Virgolini, Irene (author)
  • Kjaer, Andreas (author)
  • Modlin, Irvin M (author)
  • Uppsala universitetEndokrin tumörbiologi (creator_code:org_t)

Related titles

  • In:Endocrine Connections5:5, s. 174-1872049-3614

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view